To give you the best possible experience, this site uses cookies. Review our Privacy Policy and Terms of Service to learn more. 理解しました

ポッドキャスト Drugpatentwatch

DrugPatentWatch 公開 [search 0]
もっと
Download the App!
Get it on App Store Get it on Google Play
show episodes
 
Artwork

1
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

DrugPatentWatch

Unsubscribe
Unsubscribe
 月ごとの+
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
…   continue reading
 
Loading …
show series
 
Artwork

1
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent study published in the Future Journal of Pharmaceutical Sciences evaluates…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Unleashing Innovation: The Case for Permissionless R&D in Pharma

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This guide is designed to provide information for healthcare providers to…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Drug Excipient Business Development Reports now Available on Amazon

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking lucrative opportunities in the pharmaceutical industry, these reports offer invaluable…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
The recent paper published in PLOS ONE presents a novel approach for efficiently retrieving a substantial number of patents related to specific technologies. The authors enhance an automated patent landscaping…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers. The…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
An AI Approach to Generate Novel Pharmaceuticals using Patent Data

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A recent article published in the Journal of Cheminformatics addresses the challenge of confirming the patent status of newly developed compounds, particularly in the pharmaceutical industry, where generating novel structures…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Decoding Pfizer’s Portfolio: A New Model for Precision in Pharma Investments

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
In the ever-evolving landscape of the biotech and pharmaceutical sectors, accurate valuation of post-revenue drug assets stands as the linchpin for informed and strategic decision-making. The significance of this valuation…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Researchers from West Virginia University College of Law have conducted a study examining the frequency of drug patent invalidations based on inequitable conduct. The findings, published in JAMA, shed light…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A paper titled “Analysis of Strategy for Extending Patent Protection of Rucaparib” by Zhifeng Wang. discusses the strategies employed by pharmaceutical companies to extend the patent protection period of the…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
List of research papers citing DrugPatentWatch

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
DrugPatentWatch has published a list of research papers citing DrugPatentWatch at https://www.drugpatentwatch.com/citations/ DrugPatentWatch.com is your key to unlocking the world of pharmaceutical research. These primary literature citations can benefit researchers,…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics have revolutionized healthcare by providing effective treatments for complex diseases…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Artificial Intelligence and Machine Learning in Drug Discovery and Development

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in the pharmaceutical industry for drug discovery and development. Results The…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies. Reverse payment cases…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of generic competition. One such strategy is the use of “authorized…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020. The study…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
This article was originally published by Jiayi Chen, Zhifeng Zhao, Xinyu Wang and Jingjun Huang in Drug Repurposing – Advances, Scopes and Opportunities in Drug Discovery and is republished here…SourceDrugPatentWatch による
…   continue reading
 
Artwork

1
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents

Play Pause
Play Pause
  「あとで再生する」
  「あとで再生する」
  リスト
  気に入った
—
 
Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…SourceDrugPatentWatch による
…   continue reading
 
Loading …

クイックリファレンスガイド

トップポッドキャスト
鈴木淑子の地球は競馬でまわってる
文化放送競馬中継～今週のメインレース
ボードゲームおっぱい
聴く日経ヘッドライン
サンドウィッチマンの東北魂
トータルテンボスのぬきさしならナイト！
流行りモノ通信簿
RADIO365-TOKYO BAYSIDE RADIO STATION
町田徹のふかぼり！
足立明穂の週刊ＩＴトレンドＸ
伊藤洋一のRound Up World Now！
The other side journal
KIQTAS（キクタス）
ヴォイニッチの科学書
武田邦彦のヒバリクラブ
IchibanTalk 海外で頑張る日本人トーク
BUSINESS WARS / ビジネスウォーズ
Player FM logo
ヘルプ／よくある質問 | アップグレード | Advertise
アート|ビジネス|コメディ|経済|エンターテインメント|ニュース|政治|宗教
科学|サッカー|スポーツ|物語・ストーリーテリング|テクノロジー|事件／犯罪
著作権2024 | サイトマップ | 個人情報保護方針 | 利用規約 | | 著作権
Episode being played series thumbnail
icon icon
再生速度
シリーズの設定
1x
1x
Volume
100%
icon
icon icon
/

でPlayer FMを表示...
Player FM
Browser
Chrome
Safari
Firefox